1. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells
    Chanzhen Liu et al, 2015, Sci Rep CrossRef
  2. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Mi-Soon Han et al, 2018, Biomed Res Int CrossRef
  3. Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology
    Tarik Gheit, 2019, Front. Oncol. CrossRef
  4. null
    Eric A. Smith et al, 2015 CrossRef
  5. HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo
    Shu-jie Liao et al, 2013, J. Huazhong Univ. Sci. Technol. [Med. Sci.] CrossRef
  6. A novel “priming-boosting” strategy for immune interventions in cervical cancer
    Shujie Liao et al, 2015, Molecular Immunology CrossRef
  7. null
    Donatella Panatto et al, 2015 CrossRef
  8. Downregulation of Mad2 and BubR1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis
    Li Wang et al, 2019, J. Obstet. Gynaecol. Res. CrossRef
  9. Deregulation of Chromosome Segregation and Cancer
    Natalie L. Curtis et al, 2020, Annu. Rev. Cancer Biol. CrossRef
  10. Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle
    Christopher W. Wasson et al, 2017, Oncotarget CrossRef
  11. Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
    Talha Halim et al, 2013, Cancer Cell Int CrossRef
  12. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics
    Thong Ba Nguyen et al, 2022, Computers in Biology and Medicine CrossRef